Dishman Pharma Q4 net profit up 36% at Rs 31.3 cr

Dishman Pharma has reported a growth of 36% year-on-year in its consolidated net profit of Rs 31.3 crore for the fourth quarter of FY12.

Consolidated net sales rose 1.74% to Rs 350 crore from Rs 344 crore year-on-year.

Shares closed at Rs 43.45, up 2.24% amid heavy volumes on the BSE after hitting an intraday high of Rs 45 and low of Rs 41.65

Source: www.moneycontrol.com

Thanks,

Gaurav Agarwal

Head Dealer

DENIP Consultants Pvt Ltd